(), Sten Fredrikson
and Bengt Jönsson
Freddie Henriksson: Dept. of Economics, Stockholm School of Economics, Postal: P.O. Box 6501, SE-113 83 Stockholm, Sweden
Sten Fredrikson: Division of Neurology, Postal: Karolinska Institutet, Huddinge Hospital, SE-141 86 Huddinge, Sweden
Bengt Jönsson: Dept. of Economics, Stockholm School of Economics, Postal: Box 6501, SE-113 83 Stockholm, Sweden
Abstract: This study has used a cross-sectional, 'bottom-up' design to determine the cost to society of multiple sclerosis (MS) in Sweden in 1998. The total cost of MS was estimated at 4 868 MSEK, meaning an annual cost of 442 500 SEK per patient. Direct costs accounted for about 67% of total cost, and direct costs were dominated by the cost of personal assistants and drugs. Indirect costs accounted for about 33% of total costs and were totally dominated by the cost of long-term sickness absence from work and early retirement. Intangible costs were estimated at 2 700 MSEK. A former Swedish study on MS for 1994, using main diagnosis to calculate costs, showed the total cost to be 1 736 MSEK. Increased disability as measured by EDSS was found to have a major impact on the cost of the disease and on quality of life. Both direct, indirect and informal care costs rose significantly with increased EDSS and were higher during a relapse. Quality of life declined substantially with increased EDSS and was lower during a relapse. In summary, this study showed that a severe, chronic, disabling disease like MS that strikes early in life has major implications for both the society as a whole and for the affected patients.
42 pages, March 6, 2000
Full text files
hastef0361.pdf.zip Full text
hastef0361.pdf Full text
hastef0361.ps.zip Full text
hastef0361.ps PostScript file Full text
Questions (including download problems) about the papers in this series should be directed to Helena Lundin ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2018-01-27 00:01:24.